凯发一触即发

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

An Assay that Predicts Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis.

Mol Ther Methods Clin Dev. 2018-06; 
HeiderRobin M,SmestadJohn A,LemusHernan Nicolas,WilbanksBrandon,WarringtonArthur E,PetersJustin P,RodriguezMoses,MaherL J
Products/Services Used Details Operation
… manufacturer. Negative control oligonucleotide sequences are identified using number codes 3060 and 3202. Streptavidin purchased from Genscript (Piscataway, NJ; Z02043-5; 5 mg) was re-suspended in 1 mL PBS. Concentration …

摘要

Multiple sclerosis (MS) is a debilitating disease for which regenerative therapies are sought. We have previously described human antibodies and DNA aptamer-streptavidin conjugates that promote remyelination after systemic injection into mice infected by Theiler's murine encephalomyelitis virus. Here, we report an assay of myelin binding with results that correlate with remyelination outcome , as shown for data from a set of DNA aptamer complexes of different size and formulation. This assay will be valuable for future screening of MS regenerative therapies targeting remyelination.

关键词

aptamer,multiple sclerosis,myelin,oligodendrocyte,regenera